Gilead Sciences, Inc.GILD
Price$147.50Intrinsic value$82.7144% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $82.71median of 3 methodsbased on filings through 30 Jun 2026
Market Price $147.50Price as of 1 Oct 2026
Margin of Safety -43.9%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 10.5%/yr (balance of the path).9.4% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 610.1%Yr 79.6%Yr 89.1%Yr 98.7%Yr 108.2%
10.5% → 8.2%
Years 11–20: glide to long-run rate
Per-year rates
Yr 117.7%Yr 127.2%Yr 136.7%Yr 146.1%Yr 155.6%Yr 165.1%Yr 174.6%Yr 184.0%Yr 193.5%Yr 203.0%
8.2% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)8.2%
Discount rate (cost of equity) 7.4%
Volatility vs market (adjusted beta)0.54

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetGilead Sciences, Inc.GILDHealth Care
Valuation
P/E—
P/S6.1×
P/B15.8×
EV / Revenue6.9×
EV / EBITDA—
Profitability
Gross margin78.4%
Operating margin34.0%
Net margin-10.6%
FCF margin42.5%
Returns
ROE-27.4%
ROA-6.6%
ROIC—
Growth
Revenue growth (YoY)5.9%
5-yr fwd EPS growth9.4%
Financial strength
Debt / Equity2.22×
Current ratio1.27×
Altman Z-Score3.6
Interest coverage—
Dividend yield2.3%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.